188 related articles for article (PubMed ID: 15194848)
1. Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Rösen-Wolff A; Koch A; Friedrich W; Hahn G; Gahr M; Roesler J
Pediatr Infect Dis J; 2004 Jun; 23(6):584-6. PubMed ID: 15194848
[TBL] [Abstract][Full Text] [Related]
2. Capofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous disease.
Sallmann S; Heilmann A; Heinke F; Kerkmann ML; Schuppler M; Hahn G; Gahr M; Rösen-Wolff A; Roesler J
Pediatr Infect Dis J; 2003 Feb; 22(2):199-200. PubMed ID: 12613459
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
van 't Hek LG; Verweij PE; Weemaes CM; van Dalen R; Yntema JB; Meis JF
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1694-6. PubMed ID: 9603157
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
Sambatakou H; Guiver M; Denning D
Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):681-5. PubMed ID: 14566574
[TBL] [Abstract][Full Text] [Related]
6. Combination antifungal therapy for invasive aspergillosis.
Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
[TBL] [Abstract][Full Text] [Related]
7. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
[TBL] [Abstract][Full Text] [Related]
8. Successful antifungal combination therapy with voriconazole and caspofungin.
Schuster F; Moelter C; Schmid I; Graubner UB; Kammer B; Belohradsky BH; Führer M
Pediatr Blood Cancer; 2005 Jun; 44(7):682-5. PubMed ID: 15700260
[TBL] [Abstract][Full Text] [Related]
9. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
Castagnola E; Machetti M; Cappelli B; Molinari AC; Morreale G; Dodero P; Tomà P; Faraci M
Clin Microbiol Infect; 2004 Mar; 10(3):255-7. PubMed ID: 15008948
[TBL] [Abstract][Full Text] [Related]
11. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K
Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection.
Anttila VJ; Piilonen A; Valtonen M
Scand J Infect Dis; 2003; 35(11-12):893-4. PubMed ID: 14723374
[TBL] [Abstract][Full Text] [Related]
13. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis.
Elanjikal Z; Sörensen J; Schmidt H; Dupuis W; Tintelnot K; Jautzke G; Klingebiel T; Lehrnbecher T
Pediatr Infect Dis J; 2003 Jul; 22(7):653-6. PubMed ID: 12867844
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Clemons KV; Espiritu M; Parmar R; Stevens DA
Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
[TBL] [Abstract][Full Text] [Related]
16. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
Verweij PE; Weemaes CM; Curfs JH; Bretagne S; Meis JF
J Clin Microbiol; 2000 Oct; 38(10):3900-1. PubMed ID: 11015433
[TBL] [Abstract][Full Text] [Related]
17. Multi-azole resistance in Aspergillus fumigatus.
Howard SJ; Webster I; Moore CB; Gardiner RE; Park S; Perlin DS; Denning DW
Int J Antimicrob Agents; 2006 Nov; 28(5):450-3. PubMed ID: 17034993
[TBL] [Abstract][Full Text] [Related]
18. Disseminated invasive aspergillosis in a patient with acute leukaemia.
Gottfredsson M; Steingrímsdóttir H
Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
